Anebulo Pharmaceuticals Inc

Research Anebulo Pharmaceuticals Inc (ANEB) on Bullrun: market cap USD 16.11M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerANEB
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 16.11M
• Financial periodFY2025
• Net income-USD 8.48M

Valuation Snapshot

latest market cap is USD 16.11M.

About Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc.

Frequently asked questions

What is Anebulo Pharmaceuticals Inc's market cap?

Anebulo Pharmaceuticals Inc's market capitalization is USD 16.11M.

What does Anebulo Pharmaceuticals Inc do?

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States.